ARTICLE | Clinical News

FDA approves label expansion for AMAG's Feraheme

February 9, 2018 4:19 PM UTC

FDA approved an sNDA from AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) to expand the label of Feraheme ferumoxytol to treat iron deficiency anemia (IDA) in adults with intolerance or insufficient response to oral iron...

BCIQ Company Profiles

AMAG Pharmaceuticals Inc.